CD8A and COVID-19: SARS-CoV-2-specific CD8+ T-cell responses are rarely detected in patients with fatal COVID-19 (Dan et al., 2021) because of CD8+ T-cell depletion after overactivation, which ultimately reduces the host cellular immune response to the virus (Zheng et al., 2020; Gong et al., 2021).